U.S. researchers studying mice have discovered that when amyloid beta protein binds with alpha 7 nicotine receptors in the brain, a cascade of signals is triggered, resulting in impairments linked to Alzheimer's disease. The findings could offer hope that a modified drug known as NitroMemantine might be effective in treating the illness, researchers reported in The Journal of Neuroscience.

Full Story:

Related Summaries